Cargando…
The Effect of immunotherapy on oligometastatic non-small cell lung cancer patients by sites of metastasis
INTRODUCTION: The efficacy of immunotherapy for treatment of patients with oligometastatic non-small cell lung cancer (NSCLC) at different metastatic sites remains controversial. We investigated the effect of different metastatic sites on immunotherapy for oligometastatic NSCLC following local treat...
Autores principales: | Ma, Jia-Chun, Zhang, Jing-Xin, Wang, Fei, Yu, Jinming, Chen, Dawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702518/ https://www.ncbi.nlm.nih.gov/pubmed/36451822 http://dx.doi.org/10.3389/fimmu.2022.1039157 |
Ejemplares similares
-
Systemic Immune Activation and Responses of Irradiation to Different Metastatic Sites Combined With Immunotherapy in Advanced Non-Small Cell Lung Cancer
por: Wu, Min, et al.
Publicado: (2021) -
Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer
por: Wang, Yuchang, et al.
Publicado: (2022) -
Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer
por: Wang, Peiliang, et al.
Publicado: (2021) -
Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury
por: Zhang, Zengfu, et al.
Publicado: (2021) -
The Changing Face of Lung Cancer: Oligometastatic Renal Metastasis Post Chemo-Immunotherapy Combination
por: Matini, Elvis, et al.
Publicado: (2023)